IP Library Assignment 037115/0430
Patent Assignment
Reel/Frame 037115/0430

Change of Name

Recorded: 2015-11-16 Pages: 4
Assignor
CUREVAC GMBH
Executed: 2015-09-17
Assignee
CUREVAC AG
PAUL-EHRLICH-STR. 15, TÜBINGEN, 72076, GERMANY
Covered Properties (39)
Reversible Immobilization and/or Controlled Release of Nucleic Acid Containing Nanoparticles by (Biodegradable) Polymer Coatings
Application: 14/402,053 →
Publication: US 2015/0306249
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Tumour Antigen
Application: 14/378,572 →
Publication: US 2015/0320847
Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
Patent: 9,683,233 →
Application: 14/388,226 →
Publication: US 2015/0218554
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Allergenic Antigen or an Autoimmune Self-Antigen
Application: 14/378,591 →
Publication: US 2015/0165006
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Patent: 9,447,431 →
Application: 14/378,606 →
Publication: US 2015/0057340
Artificial Nucleic Acid Molecules Comprising a 5'TOP Utr
Application: 14/388,224 →
Publication: US 2015/0050302
An Rna Vector with an Open Reading Frame, an Albumin 3' Utr, and a Histone Stem Loop
Patent: 9,890,391 →
Application: 14/388,220 →
Publication: US 2015/0184195
Pharmaceutical Composition Comprising a Polymeric Carrier Cargo Complex and at Least One Protein or Peptide Antigen
Application: 14/375,215 →
Publication: US 2015/0118264
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Pathogenic Antigen
Patent: 9,669,089 →
Application: 14/378,538 →
Publication: US 2015/0093413
Negatively Charged Nucleic Acid Comprising Complexes for Immunostimulation
Application: 14/375,364 →
Publication: US 2015/0118183
Vaccine Composition Comprising Complexed Immunostimulatory Nucleic Acids and Antigens Packaged with Disulfide-Linked Polyethyleneglycol/Peptide Conjugates
Patent: 9,421,255 →
Application: 13/824,449 →
Publication: US 2013/0259879
Combination of Vaccination and Inhibition of Mhc Class I Restricted Antigen Presentation
Patent: 9,737,595 →
Application: 13/824,502 →
Publication: US 2013/0280283
Vaccination in Newborns and Infants
Patent: 9,623,095 →
Application: 13/824,705 →
Publication: US 2013/0336998
Vaccination in Elderly Patients
Application: 13/824,589 →
Publication: US 2013/0295043
Disulfide-Linked Polyethyleneglycol/Peptide Conjugates for the Transfection of Nucleic Acids
Patent: 8,703,906 →
Application: 13/378,241 →
Publication: US 2012/0219573
Mannose-Containing Solution for Lyophilization, Transfection and/or Injection of Nucleic Acids
Application: 13/509,564 →
Publication: US 2012/0258046
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
Patent: 9,234,013 →
Application: 13/321,474 →
Publication: US 2013/0129754
Complexation of Nucleic Acids with Disulfide-Crosslinked Cationic Components for Transfection and Immunostimulation
Patent: 8,968,746 →
Application: 13/203,653 →
Publication: US 2013/0142818
Composition Comprising a Complexed (M)Rna and a Naked Mrna for Providing or Enhancing an Immunostimulatory Response in a Mammal and Uses Thereof
Patent: 9,572,874 →
Application: 12/994,407 →
Publication: US 2011/0250225
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
Application: 12/682,187 →
Publication: US 2010/0305196
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application: 12/787,755 →
Publication: US 2010/0239608
Immunostimulation by Chemically Modified Rna
Application: 12/791,233 →
Publication: US 2010/0303851
Pharmaceutical Composition Containing a Stabilised Mrna Optimised for Translation in Its Coding Regions
Application: 12/787,566 →
Publication: US 2011/0077287
Composition for Treating Lung Cancer, Particularly of Non-Small Lung Cancers (Nsclc)
Application: 12/682,213 →
Publication: US 2010/0291156
Complexes of Rna and Cationic Peptides for Transfection and for Immunostimulation
Application: 12/676,015 →
Publication: US 2010/0203076
Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant
Patent: 9,226,959 →
Application: 12/672,442 →
Publication: US 2012/0021043
Disulfide-Linked Polyethyleneglycol/Peptide Conjugates for the Transfection of Nucleic Acids
Application: 12/553,559 →
Publication: US 2011/0053829
Rna-Coded Antibody
Application: 12/522,214 →
Publication: US 2010/0189729
Method for Purifying Rna on a Preparative Scale by Means of Hplc
Patent: 8,383,340 →
Application: 12/520,172 →
Publication: US 2010/0048883
Nucleic Acid Comprising GlXmGn as an Immune-Stimulating Agent/Adjuvant
Application: 13/492,787 →
Publication: US 2013/0121988
Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
Application: 12/375,178 →
Publication: US 2009/0324584
Injection Solution for Rna
Application: 11/914,945 →
Publication: US 2008/0267873
Combination Therapy for Immunostimulation
Application: 13/361,686 →
Publication: US 2012/0213818
Combination Therapy for Immunostimulation
Application: 10/580,746 →
Publication: US 2008/0025944
Transfection of Blood Cells with Mrna for Immune Stimulation and Gene Therapy
Application: 13/174,081 →
Publication: US 2012/0009221
Application of Mrna for Use as a Therapeutic Agent for Tumorous Diseases
Patent: 8,217,016 →
Application: 10/870,110 →
Publication: US 2005/0059624
Immunostimulation by chemically modified RNA
Application: 11/025,858 →
Publication: US 2005/0250723
Transfection of blood cells with mRNA for immune stimulation and gene therapy
Application: 11/342,392 →
Publication: US 2006/0188490
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
Application: 10/729,830 →
Publication: US 2005/0032730
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 29, 2010
From: FOTIN-MLECZEK, MARIOLA; VOSS, SOHNKE
To: CUREVAC GMBH
Reel/Frame 025426/0800 →
Assignment of Assignor's Interest Apr 26, 2012
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 028113/0239 →
Assignment of Assignor's Interest May 11, 2012
From: BAUMHOF, PATRICK; SCHLAKE, THOMAS
To: QIAGEN GMBH
Reel/Frame 028197/0025 →
Assignment of Assignor's Interest Jul 11, 2012
From: MUTZKE, THORSTEN
To: CUREVAC GMBH
Reel/Frame 028528/0196 →
Assignment of Assignor's Interest Feb 14, 2013
From: BAUMHOF, PATRICK; VOSS, SOHNKE; KRAMPS, THOMAS; KALLEN, KARL-JOSEF
To: CUREVAC GMBH
Reel/Frame 029816/0134 →
Assignment of Assignor's Interest Jun 3, 2013
From: LORENZ, CHRISTINA; FOTIN-MLECZEK, MARIOLA; KALLEN, KARL-JOSEF
To: CUVEVAC GMBH
Reel/Frame 030532/0840 →
Assignment of Assignor's Interest Jun 17, 2013
From: BAUMHOF, PATRICK; KALLEN, KARL-JOSEF; FOTIN-MLECZEK, MARIOLA
To: CUREVAC GMBH
Reel/Frame 030624/0228 →
Assignment of Assignor's Interest Jul 10, 2013
From: KALLEN, KARL-JOSEF; KRAMPS, THOMAS; SCHNEE, MARGIT; PETSCH, BENJAMIN
To: CUREVAC GMBH
Reel/Frame 030771/0875 →
Assignment of Assignor's Interest Jul 23, 2013
From: KALLEN, KARL-JOSEF; KRAMPS, THOMAS; SCHNEE, MARGIT; PETSCH, BENJAMIN
To: CUREVAC GMBH
Reel/Frame 030861/0658 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 028197 Frame 0025. Assignor(S) Hereby Confirms the Name of the Assignee Should Be "Curevac Gmbh". Aug 1, 2013
From: BAUMHOF, PATRICK; SCHLAKE, THOMAS
To: CUREVAC GMBH
Reel/Frame 030961/0881 →
Corrective Assignment to Correct the Name of the Assignee from "Cuvevac Gmbh" to "Curevac Gmbh" Previously Recorded on Reel 030532 Frame 0840. Assignor(S) Hereby Confirms the Entire Right, Title and Interest in, to and Under Said Improvements and Said Application. Sep 22, 2013
From: LORENZ, CHRISTINA; FOTIN-MLECZEK, MARIOLA; KALLEN, KARL-JOSEF
To: CUREVAC GMBH
Reel/Frame 031257/0731 →
Assignment of Assignor's Interest Sep 4, 2014
From: BAUMHOF, PATRICK
To: CUREVAC GMBH
Reel/Frame 033668/0652 →
Assignment of Assignor's Interest Nov 3, 2014
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 034087/0069 →
Assignment of Assignor's Interest Nov 25, 2014
From: BAUMHOF, PATRICK; KRAMPS, THOMAS; VOSS, SOHNKE; KALLEN, KARL-JOSEF
To: CUREVAC GMBH
Reel/Frame 034264/0001 →
Assignment of Assignor's Interest Dec 1, 2014
From: THESS, ANDREAS
To: CUREVAC GMBH
Reel/Frame 034288/0643 →
Assignment of Assignor's Interest Dec 10, 2014
From: THESS, ANDREAS; KALLEN, KARL-JOSEF
To: CUREVAC GMBH
Reel/Frame 034462/0576 →
Assignment of Assignor's Interest Dec 17, 2014
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 034534/0395 →
Assignment of Assignor's Interest Feb 4, 2015
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 034890/0952 →
Assignment of Assignor's Interest Apr 13, 2015
From: BAUMHOF, PATRICK; WENDEL, HANS-PETER; NOLTE, ANDREA; WALKER, TOBIAS
To: CUREVAC GMBH
Reel/Frame 035397/0789 →
Assignment of Assignor's Interest May 23, 2015
From: THESS, ANDREAS
To: CUREVAC GMBH
Reel/Frame 035703/0289 →
Assignment of Assignor's Interest Sep 21, 2015
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 036607/0654 →
Change of Name Jan 5, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062300/0261 →
Change of Name Jan 11, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062356/0473 →
Change of Name Feb 6, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062684/0132 →
Change of Name Feb 18, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062799/0268 →